MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine

MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidineMTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine, Published online: 05 December 2017; doi:10.1038/tpj.2017.48MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine

Source: The Pharmacogenomics Journal - December 5, 2017 Category: Drugs & Pharmacology Authors: G Visani F Loscocco A Ruzzo S Galimberti F Graziano M T Voso E Giacomini C Finelli E Ciabatti E Fabiani S Barulli A Volpe D Magro P Piccaluga F Fuligni M Vignetti P Fazi A Piciocchi E Gabucci M Rocchi M Magnani A Isidori Source Type: research